OR WAIT null SECS
Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.
Human milk oligosaccharides could help treat some of the gut disruptions patients with depression often have.
There is an obvious connection with diet, where often patients with a psychiatric disorder will also have poor diets, increasing the risk of diseases like inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).
One potential option to supplement dietary changes could be human milk oligosaccharides (HMOs). HMOs areknown to be beneficial for infants as opposed to other forms of milk and have been explored as a potential treatment for IBS and other gastrointestinal disorders in the past.
In this episode of DocTalk, Ardythe L. Morrow, PhD, Professor of Pediatrics at Cincinnati Children’s Hospital Medical Center and Director of the Center for Interdisciplinary Research in Human Milk and Lactation, discussed how HMOs could be a promising answer to this problem among patients with psychiatric disorders, including major depressive disorder, anxiety, and autism spectrum disorder.
Morrow said more research is needed in this field, but what was found so far has been promising.
She also spoke about the importance of diet and why it is difficult to implement for patients but could ultimately aid in reducing the risk of diseases like IBD and IBS, while also alleviating some of the symptoms of depression.